Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 2/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.40 |
| ▸ | CPA1 | P15085 | 1/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.36 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.35 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | LAP3 | P28838 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26696144 | 0.85 | USP2 (0.41) | SLC1A3SLC1A2CPA1SLC1A1CA2 | |
| Ammonia Solution, Strong SCHEMBL26696147 | 0.83 | USP2 (0.39) | SLC1A3SLC1A2CPA1SLC1A1CA2 | |
| SCHEMBL25633077 | 0.83 | ALDH1A1 (0.40) | SLC1A3SLC1A2CPA1SLC1A1CA2 | |
| SCHEMBL17087691 | 0.81 | CACNA2D1 (0.42) | SLC1A3SLC1A2CPA1CA2CA1 | |
| SCHEMBL21343979 | 0.81 | SLC1A3 (0.38) | SLC1A3SLC1A2CPA1SLC1A1CA2 | |
| SCHEMBL5372259 | 0.81 | — | — | |
| SCHEMBL28141545 | 0.79 | SLC1A3 (0.41) | SLC1A3SLC1A2CPA1SLC1A1CA2 | |
| SCHEMBL3782665 | 0.79 | SLC1A3 (0.43) | SLC1A3SLC1A2CPA1SLC1A1CA2 | |
| SCHEMBL20489995 | 0.77 | SLC1A3 (0.41) | SLC1A3SLC1A2CPA1SLC1A1CA2 | |
| SCHEMBL3657031 | 0.77 | KISS1R (0.50) | SLC1A3SLC1A2CPA1SLC1A1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120088770-A1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | PRISM BIOLAB CORPORATION (JP) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088770-A1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | PLOD3, COL1A1, THPO | SLC1A3 4680/4885SLC1A2 4620/4885CPA1 1153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.